Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis

Wechalekar, 2016, Systemic amyloidosis, Lancet, 387, 2641, 10.1016/S0140-6736(15)01274-X Gertz, 2016, Immunoglobulin light chain amyloidosis: 2016 update on diagnosis, prognosis, and treatment, Am J Hematol, 91, 947, 10.1002/ajh.24433 Kyle, 1992, Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989, Blood, 79, 1817, 10.1182/blood.V79.7.1817.1817 Merlini, 2011, Amyloidosis: pathogenesis and new therapeutic options, J Clin Oncol, 29, 1924, 10.1200/JCO.2010.32.2271 Palladini, 2016, What is new in diagnosis and management of light chain amyloidosis?, Blood, 128, 159, 10.1182/blood-2016-01-629790 Gertz, 2018, Immunoglobulin light chain amyloidosis: 2018 update on diagnosis, prognosis, and treatment, Am J Hematol, 93, 1169, 10.1002/ajh.25149 Caccialanza, 2015, Nutritional counseling improves quality of live and preserves body weight in systemic immunoglobulin light-chain (AL) amyloidosis, Nutrition, 31, 1228, 10.1016/j.nut.2015.04.011 Saunders, 2010, Malnutrition: causes and consequences, Clin Med (Lond), 10, 624, 10.7861/clinmedicine.10-6-624 Ryan, 2019, Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival, Nutrition, 67 Correia, 2003, The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis, Clin Nutr, 22, 235, 10.1016/S0261-5614(02)00215-7 Rasheed, 2013, Malnutrition and quality of life in older people: a systematic review and meta-analysis, Ageing Res Rev, 12, 561, 10.1016/j.arr.2012.11.003 Cederholm TA, Bosaeus IB, Barazzoni RC, et al. Diagnostic criteria for malnutrition e an ESPEN Consensus Statement. Reber, 2019, Nutritional risk screening and assessment, J Clin Med, 8, 1065, 10.3390/jcm8071065 Fink, 2015, Subjective global assessment of nutritional status e A systematic review of the literature, Clinical Nutrition, 34, 785, 10.1016/j.clnu.2014.12.014 Gertz, 2020, Systemic amyloidosis recognition, prognosis, and therapy: a systematic review, JAMA, 324, 79, 10.1001/jama.2020.5493 Sattianayagam, 2013, A prospective study of nutritional status in immunoglobulin light chain amyloidosis, Haematologica, 98, 136, 10.3324/haematol.2012.070359 Caccialanza, 2014, Malnutrition at diagnosis predicts mortality in patients with systemic immunoglobulin light-chain amyloidosis independently of cardiac stage and response to treatment, JPEN J Parenter Eternal Nutr, 38, 891, 10.1177/0148607113501328 Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS, 6 Cederholm, 2019, ESPEN Endorsed Recommendation GLIM criteria for the diagnosis of malnutrition e A consensus report from the global clinical nutrition community, Clin. Nutr., 38, 1, 10.1016/j.clnu.2018.08.002 Caccialanza, 2020, Bioelectrical impedance vector analysis-derived phase angle predicts survival in patients with systemic immunoglobulin light-chain amyloidosis, Amyloid, 27, 168, 10.1080/13506129.2020.1737004 Bartier, 2019, Pharyngo-laryngeal involvement in systemic amyloidosis with cardiac involvement: a prospective observational study, Amyloid, 26, 216, 10.1080/13506129.2019.1646639 Szczygiel, 2017, Impaired right ventricular function as a predictor of early mortality in patients with light-chain cardiac amyloidosis assessed in a cardiology department, Pol Arch Intern Med, 127, 854 Liewluck, 2017, Characterization of isolated amyloid myopathy, Eur J Neurol, 24, 1437, 10.1111/ene.13448 Decourt, 2016, Trends in survival and renal recovery in patients with multiple myeloma or light-chain amyloidosis on chronic dialysis, Clin J Am Soc Nephrol, 11, 431, 10.2215/CJN.06290615 Lim, 2015, Clinical features and outcomes of systemic amyloidosis with gastrointestinal involvement: a single-center experience, Korean J Intern Med, 30, 496, 10.3904/kjim.2015.30.4.496 Said, 2015, Gastric amyloidosis: clinicopathological correlations in 79 cases from a single institution, Hum Pathol, 46, 491, 10.1016/j.humpath.2014.12.009 Caccialanza, 2013, Serum prealbumin: An independent marker of short-term energy intake in the presence of multiple-organ disease involvement, Nutrition, 29, 580, 10.1016/j.nut.2012.08.007 Aj, 2013, Amyloidosis of the gastrointestinal tract: a 13-year, single-center, referral experience, Haematologica, 98, 141, 10.3324/haematol.2012.068155 Hermandez-Reyes, 2012, Systemic immunoglobulin light-chain amyloidosis (AL) in Mexico: a single institution, 30-year experience, Rev Invest Clin, 64, 604 Caccialanza, 2012, Nutritional status independently affects quality of life of patients with systemic immunoglobulin light-chain (AL) amyloidosis, Annals of Hematology, 91, 399, 10.1007/s00277-011-1309-x Madsen, 2009, Primary (AL) amyloidosis with gastrointestinal involvement, Scand J Gastroenterol, 44, 708, 10.1080/00365520902783717 Caccialanza, 2006, Nutritional status of outpatients with systemic immunoglobulin light-chain amyloidosis, Am J Clin Nutr, 83, 350, 10.1093/ajcn/83.2.350 Gertz MA, Blood E, Vesole DH, et al. A multicenter phase 2 trial of stem cell transplantation for immunoglobulin light-chain amyloidosis (E4A97): an eastern cooperative oncology group study. bone marrow transplant. 2004;34:149-54. doi:10.1038/sj.bmt.1704539. PMID: 15156165. Park, 2003, Primary (AL) hepatic amyloidosis clinical features and natural history in 98 patients, Medicine (Baltimore), 82, 291, 10.1097/01.md.0000091183.93122.c7 Hayman, 2001, Primary systemic amyloidosis: a cause of malabsorption syndrome, Am J Med, 111, 535, 10.1016/S0002-9343(01)00919-6 Dispenzieri, 2001, Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survival, J Clin Oncol, 19, 3350, 10.1200/JCO.2001.19.14.3350 Dubrey, 1998, The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement, QJM, 91, 141, 10.1093/qjmed/91.2.141 Kyle, 1995, Primary systemic amyloidosis: clinical and laboratory features in 474 cases, Semin Hematol, 32, 45 Menke, 1993, Symptomatic gastric amyloidosis in patients with primary systemic amyloidosis, Mayo Clin Proc, 68, 763, 10.1016/S0025-6196(12)60634-X OrganizationWH: WHO/Europe Nutrition – Body Mass Index – BMI Li, 2011, Comparison of PG-SGA, SGA and body-composition measurement in detecting malnutrition among newly diagnosed lung cancer patients in stage IIIB/IV and benign conditions, Med. Oncol., 28, 689, 10.1007/s12032-010-9534-z Jeejeebhoy, 2015, Nutritional assessment: comparison of clinical assessment and objective variables for the prediction of length of hospital stay and readmission, Am J Clin Nutr, 101, 10.3945/ajcn.114.098665 Silva Fink, 2015, Subjective global assessment of nutritional status – a systemic review of the literature, Clin Nutr, 34, 785, 10.1016/j.clnu.2014.12.014 Lin, 2016, Review of nutritional screening and assessment tools and clinical outcomes in heart failure, Heart Fail Rev, 21, 549, 10.1007/s10741-016-9540-0 Yost, 2014, Short-form nutrition assessment in patients with advanced heart failure evaluated for ventricular assist device placement or cardiac transplantation, Nutr Clin Pract, 29, 686, 10.1177/0884533614535269 Caillet, 2017, Association between cachexia, chemotherapy and outcomes in older cancer patients: A systematic review, Clinical Nutrition, 36, 1473, 10.1016/j.clnu.2016.12.003 Hickson, 2006, Malnutrition and ageing, Postgrad Med J, 82, 2, 10.1136/pgmj.2005.037564 Rezk, 2019, Bioimpedance vector analysis for the detection of extracellular volume overload and sarcopenia in systemic AL amyloidosis, Br J Haematol, 185, 977, 10.1111/bjh.15675 Cook, 2005, Use of BMI in the assessment of undernutrition in older subjects: Reflecting on practice, Proceed Nutri Soc, 64, 313, 10.1079/PNS2005437 Sanchorawala, 2017, A longitudinal evaluation of health-related quality of life in patients with AL amyloidosis: associations with health outcomes over time, Br J Haematol, 179, 461, 10.1111/bjh.14889 Bayliss, 2017, The burden of amyloid light chain amyloidosis on health-related quality of life, Orphanet J Rare Dis, 12, 15, 10.1186/s13023-016-0564-2 Seldin, 2004, Improvement in quality of life of patients with AL amyloidosis treated with highdose melphalan and autologous stem cell transplantation, Blood, 104, 1888, 10.1182/blood-2004-01-0089 Cotogni, 2018, Bioelectrical impedance analysis for monitoring cancer patients receiving chemotherapy and home parenteral nutrition, BMC Cancer, 18, 990, 10.1186/s12885-018-4904-6 Pereira, 2018, The prognostic role of phase angle in advanced cancer patients: a systematic review, Nutr Clin Pract, 33, 813, 10.1002/ncp.10100 Kastritis, 2021, Daratumumab-based treatment for immunoglobulin light-chain amyloidosis, N Engl J Med, 385, 46, 10.1056/NEJMoa2028631 Sanchorawala, 2020, Health-related quality of life in patients with AL amyloidosis treated with daratumumab, bortezomib, cyclophosphamide, and dexamethasone: results from the phase 3 ANDROMEDA study